Pustular
Showing 1 - 25 of 716
CorEvitas Generalized Pustular Psoriasis Drug Safety and
Enrolling by invitation
- Generalized Pustular Psoriasis
-
Waltham, MassachusettsCorEvitas, LLC
Oct 23, 2023
Generalized Pustular Psoriasis Trial in Shandong (HB0034)
Not yet recruiting
- Generalized Pustular Psoriasis
-
Shandong, Shandong, ChinaShandong Provincial Dermatology Hospital
Aug 22, 2022
Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab)
Completed
- Generalized Pustular Psoriasis
- Imsidolimab
-
Encino, California
- +12 more
Mar 2, 2022
Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)
Not yet recruiting
- Palmoplantar Psoriasis
- Genital Psoriasis
- Deucravacitinib
- Placebo
-
Birmingham, Alabama
- +24 more
Sep 12, 2023
Generalized Pustular Psoriasis, Erythrodermic Psoriasis Trial in Japan (Ixekizumab)
Completed
- Generalized Pustular Psoriasis
- Erythrodermic Psoriasis
-
Nagoya, Aichi, Japan
- +6 more
Jul 21, 2021
Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau, Pustular Psoriasis Trial run by the NIAMS (Anakinra)
Completed
- Sneddon-Wilkinson
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2021
Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab, Placebo)
Recruiting
- Generalized Pustular Psoriasis
- Imsidolimab
- Placebo
-
Largo, Florida
- +66 more
Sep 12, 2022
Pustular Psoriasis (PP) Trial in Italy, Singapore, Switzerland (biological sampling, Phenotypic description, Photography)
Recruiting
- Pustular Psoriasis (PP)
- biological sampling
- +2 more
-
Rome, Italy
- +3 more
Jul 5, 2022
Evaluate Safety and Efficacy of Cosentyx in Pediatric PsV, PsA,
Recruiting
- Psoriasis Vulgaris
- +2 more
- Cosentyx
-
Nagoya-city, Aichi, Japan
- +23 more
Aug 3, 2022
Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab, Placebo)
Completed
- Generalized Pustular Psoriasis
- Spesolimab
- Placebo
-
Birmingham, Alabama
- +36 more
Feb 11, 2022
Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A
Unknown status
- Palmoplantar Pustulosis
- Generalized Pustular Psoriasis
- prevalence/incidence
- (no location specified)
Sep 22, 2020
Moderate-to-severe Psoriasis in Adults: Update of French
Recruiting
- Psoriasis
- +10 more
- Experts consensus
-
Paris, FranceCenter of Evidence of Dermatology
Nov 21, 2021
Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo)
Completed
- Psoriasis
- Guselkumab 100 mg
- Placebo
-
Bordeaux, France
- +25 more
Dec 30, 2021
Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab high dose, Imsidolimab low dose, Placebo)
Recruiting
- Generalized Pustular Psoriasis
- Imsidolimab high dose
- +2 more
-
Largo, Florida
- +59 more
May 2, 2022
Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis Trial in Japan (Placebo, Certolizumab
Completed
- Moderate to Severe Psoriasis
- Generalized Pustular Psoriasis and Erythrodermic Psoriasis
- Placebo
- Certolizumab Pegol
-
Asahikawa, Japan
- +32 more
Dec 13, 2021
Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Tokyo (Brodalumab 210mg SC)
Completed
- Psoriasis Vulgaris
- +3 more
- Brodalumab 210mg SC
-
Tokyo, JapanThe Jikei University Scoole of Medicine
Dec 5, 2019
Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Chiyoda-ku (KHK4827 140mg SC,
Completed
- Psoriasis Vulgaris
- +3 more
- KHK4827 140mg SC
- KHK4827 210mg SC
-
Chiyoda-ku, Tokyo, JapanFor additional information regarding investigative sites for thi
Nov 13, 2019
Rosacea Trial (15% Trichloroacetic acid peel, 30% Salicylic acid peel)
Not yet recruiting
- Rosacea
- 15% Trichloroacetic acid peel
- 30% Salicylic acid peel
- (no location specified)
Jan 31, 2022